|
29 Companies |
|
28 Products |
|
28 Products |
|
27 Mechanisms of Action |
|
0 Trials |
|
447 News |
|
| «12345678910» |
- Enrollment closed: Topical PDT Cream Without Irradiation Source in the Acne Treatment (clinicaltrials.gov) - Jan 9, 2015
P=N/A, N=44, Active, not recruiting, Sponsor: Seoul National University Hospital
Recruiting --> Active, not recruiting
- |||| omiganan (CLS001) / Maruho
Trial completion: Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris (clinicaltrials.gov) - Jan 6, 2015
P2, N=327, Completed, Sponsor: Cutanea Life Sciences, Inc.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||||||||| Seysara (sarecycline) / Paratek, Almirall
New P3 trial: Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne (clinicaltrials.gov) - Dec 24, 2014
P3, N=1000, Recruiting, Sponsor: Warner Chilcott
- || isotretinoin / Generic mfg.
Trial primary completion date: Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment (clinicaltrials.gov) - Dec 19, 2014
P=N/A, N=250, Recruiting, Sponsor: Duke University
Active, not recruiting --> Completed Trial primary completion date: Jun 2014 --> Jun 2015
- |||||||||| Seysara (sarecycline) / Paratek, Almirall
New P3 trial: Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne (clinicaltrials.gov) - Dec 19, 2014
P3, N=1000, Recruiting, Sponsor: Warner Chilcott
- Clinical: Topical PDT Cream Without Irradiation Source in the Acne Treatment (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=44, Recruiting, Sponsor: Seoul National University Hospital
- |||| Trial completion: A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions (clinicaltrials.gov) - Dec 10, 2014
P4, N=90, Completed, Sponsor: GlaxoSmithKline
Trial primary completion date: Jun 2014 --> Jun 2015 Recruiting --> Completed
- | Trial completion, Enrollment change: Feasibility Study: Ulthera (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=24, Completed, Sponsor: Ulthera, Inc
Recruiting --> Completed Active, not recruiting --> Completed | N=30 --> 24
- Enrollment change, Trial withdrawal: Topical 5-ALA-PDT With Blu-U Therapy Versus Topical 5-ALA With Pulse Dye Laser In Treating Recalcitrant Acne Vulgaris (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=0, Withdrawn, Sponsor: University of Chicago
Active, not recruiting --> Completed | N=30 --> 24 N=10 --> 0 | Terminated --> Withdrawn
- | MTC 896 / Mimetica
New P1/2 trial: Pharmacokinetic Study of MTC896 Gel in Subjects With Acne (clinicaltrials.gov) - Nov 18, 2014
P1/2, N=45, Recruiting, Sponsor: Mimetica Pty Limited
- |||| Trial completion: Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris. (clinicaltrials.gov) - Nov 18, 2014
P2, N=236, Completed, Sponsor: Galderma R&D
N=10 --> 0 | Terminated --> Withdrawn Active, not recruiting --> Completed
- ||||||| adapalene/benzoyl peroxide / Generic mfg.
Trial completion: Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris. (clinicaltrials.gov) - Nov 18, 2014
P3, N=417, Completed, Sponsor: Galderma R&D
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| dapsone / Generic mfg.
Trial completion: A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris (clinicaltrials.gov) - Nov 18, 2014
P3, N=2156, Completed, Sponsor: Allergan
Active, not recruiting --> Completed Recruiting --> Completed
- ||||||| dapsone / Generic mfg.
Trial completion: Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris (clinicaltrials.gov) - Nov 18, 2014
P3, N=2241, Completed, Sponsor: Allergan
Recruiting --> Completed Recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: Nociceptive Processing in Acute Cutaneous Nerve Entrapment Syndrome (clinicaltrials.gov) - Nov 17, 2014
P=N/A, N=50, Completed, Sponsor: Radboud University
Recruiting --> Completed Enrolling by invitation --> Completed | N=40 --> 50 | Trial primary completion date: Sep 2013 --> May 2014
- |||| berdazimer sodium (SB204) / Sato Pharma, Novan
Enrollment open: P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Nov 6, 2014
P2, N=200, Recruiting, Sponsor: Novan, Inc.
Enrolling by invitation --> Completed | N=40 --> 50 | Trial primary completion date: Sep 2013 --> May 2014 Not yet recruiting --> Recruiting
- ||||| adapalene / Generic mfg.
Enrollment closed: An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne (clinicaltrials.gov) - Nov 6, 2014
P3, N=120, Active, not recruiting, Sponsor: Mahidol University
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Enrollment closed: Ultherapy (clinicaltrials.gov) - Oct 22, 2014
P=N/A, N=20, Active, not recruiting, Sponsor: Ulthera, Inc
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | Trial completion: Clinical Study for Topical Lupeol in Acne (clinicaltrials.gov) - Sep 29, 2014
P=N/A, N=16, Completed, Sponsor: Seoul National University Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- berdazimer sodium (SB204) / Sato Pharma, Novan
New P1 trial: A Phase 1 Study Assessing Local Cutaneous Effects of SB204 (clinicaltrials.gov) - Sep 28, 2014
P1, N=8, Completed, Sponsor: Novan, Inc.
- Enrollment open, Combination therapy: Microneedling Plus the Universal Peel For Acne Scarring (clinicaltrials.gov) - Sep 28, 2014
P=N/A, N=15, Recruiting, Sponsor: Englewood Hospital and Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
Trial completion: Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Sep 22, 2014
P4, N=221, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||| berdazimer sodium (SB204) / Sato Pharma, Novan
New P2 trial: P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Sep 19, 2014
P2, N=200, Not yet recruiting, Sponsor: Novan, Inc.
- ||| omiganan (CLS001) / Maruho
Enrollment closed: Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris (clinicaltrials.gov) - Sep 19, 2014
P2, N=320, Active, not recruiting, Sponsor: Cutanea Life Sciences, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment open: Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Sep 11, 2014
P=N/A, N=310, Recruiting, Sponsor: Sebacia, Inc.
Recruiting --> Active, not recruiting Active, not recruiting --> Recruiting
- Enrollment open: Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Sep 5, 2014
P=N/A, N=300, Recruiting, Sponsor: Sebacia, Inc.
Active, not recruiting --> Recruiting Withheld --> Recruiting
- ||||||| adapalene/benzoyl peroxide / Generic mfg.
Trial completion: A Long Term Study of GK530G in Subjects With Acne Vulgaris (clinicaltrials.gov) - Sep 5, 2014
P3, N=436, Completed, Sponsor: Galderma R&D
Withheld --> Recruiting Active, not recruiting --> Completed
- ||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
Enrollment closed, Trial primary completion date: Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Aug 19, 2014
P4, N=221, Active, not recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Jun 2014
- Clinical: Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Aug 18, 2014
P=N/A, N=310, Active, not recruiting, Sponsor: Sebacia, Inc.
- Clinical: Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Aug 15, 2014
P=N/A, N=0, Withheld, Sponsor: [Redacted]
- ||| tazarotene topical / Generic mfg.
New P1 trial: Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris (clinicaltrials.gov) - Aug 15, 2014
P1, N=72, Recruiting, Sponsor: Allergan
- Trial completion: Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone (clinicaltrials.gov) - Aug 12, 2014
P=N/A, N=97, Completed, Sponsor: University of California, Davis
Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Jun 2014 Active, not recruiting --> Completed
- Enrollment closed: Clinical Study for Topical Lupeol in Acne (clinicaltrials.gov) - Aug 11, 2014
P=N/A, N=16, Active, not recruiting, Sponsor: Seoul National University Hospital
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- adapalene/benzoyl peroxide / Generic mfg.
Enrollment closed: Dermatologists' Educational Demonstration for Epiduo Application (clinicaltrials.gov) - Aug 11, 2014
P=N/A, N=65, Active, not recruiting, Sponsor: Seoul National University Hospital
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Clinical: Comparison of Efficacy Between Fractional Microneedling Radiofrequency and Bipolar Radiofrequency for Acne Scar (clinicaltrials.gov) - Aug 4, 2014
P=N/A, N=23, Completed, Sponsor: Seoul National University Hospital
- Clinical: Clinical Study for Topical Lupeol in Acne (clinicaltrials.gov) - Aug 1, 2014
P=N/A, N=16, Recruiting, Sponsor: Seoul National University Hospital
- | adapalene / Generic mfg.
Enrollment open: An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne (clinicaltrials.gov) - Aug 1, 2014
P3, N=120, Recruiting, Sponsor: Mahidol University
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- || Trial primary completion date: Study to Investigate the Irritation Potential of GSK1940029 Gel (clinicaltrials.gov) - Jul 28, 2014
P1, N=71, Recruiting, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Trial primary completion date: May 2014 --> Oct 2014
- Trial primary completion date: Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029 (clinicaltrials.gov) - Jul 28, 2014
P1, N=48, Recruiting, Sponsor: GlaxoSmithKline
Trial primary completion date: May 2014 --> Oct 2014 Trial primary completion date: Feb 2014 --> Oct 2014
- |||| Trial completion, Trial primary completion date: BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris (clinicaltrials.gov) - Jul 14, 2014
P2, N=300, Completed, Sponsor: Braintree Laboratories
Trial primary completion date: Feb 2014 --> Oct 2014 Active, not recruiting --> Completed | Trial primary completion date: Feb 2014 --> Nov 2013
- Enrollment closed: Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone (clinicaltrials.gov) - Jul 12, 2014
P=N/A, N=100, Active, not recruiting, Sponsor: University of California, Davis
Active, not recruiting --> Completed | Trial primary completion date: Feb 2014 --> Nov 2013 Recruiting --> Active, not recruiting
- || dapsone / Generic mfg.
Trial primary completion date: A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris (clinicaltrials.gov) - Jul 8, 2014
P4, N=67, Active, not recruiting, Sponsor: Allergan
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2014 --> Jun 2014
- ||| dapsone / Generic mfg.
Enrollment closed, Trial primary completion date: A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris (clinicaltrials.gov) - Jul 8, 2014
P4, N=67, Active, not recruiting, Sponsor: Allergan
Trial primary completion date: Sep 2014 --> Jun 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Jun 2014
- ||||| Humira (adalimumab) / AbbVie
Enrollment closed: PIONEER (OLE): Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa (clinicaltrials.gov) - Jul 4, 2014
P3, N=540, Active, not recruiting, Sponsor: AbbVie (prior sponsor, Abbott)
Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Jun 2014 Enrolling by invitation --> Active, not recruiting
- Combination therapy: Microneedling Plus the Universal Peel For Acne Scarring (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=15, Not yet recruiting, Sponsor: Englewood Hospital and Medical Center
- || adapalene / Generic mfg.
New P3 trial: An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne (clinicaltrials.gov) - Jun 27, 2014
P3, N=120, Not yet recruiting, Sponsor: Mahidol University
- | berdazimer sodium (SB204) / Sato Pharma, Novan
New P1 trial: A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris (clinicaltrials.gov) - Jun 18, 2014
P1, N=18, Active, not recruiting, Sponsor: Novan, Inc.
- ||| Enrollment closed: Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris. (clinicaltrials.gov) - Jun 18, 2014
P2, N=234, Active, not recruiting, Sponsor: Galderma R&D
Enrolling by invitation --> Active, not recruiting Recruiting --> Active, not recruiting
- ||||| adapalene/benzoyl peroxide / Generic mfg.
Enrollment closed: Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris. (clinicaltrials.gov) - Jun 18, 2014
P3, N=412, Active, not recruiting, Sponsor: Galderma R&D
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||||||||| tazarotene topical / Generic mfg.
New P3 trial: Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Jun 12, 2014
P3, N=1737, Recruiting, Sponsor: G & W Laboratories Inc.